FAQS

A clinical study is a medical research study in people. The potential new medicine or device being studied only enters a clinical study after researchers test it in the laboratory. If it looks promising, scientists carefully test and collect data about the potential medicine through clinical studies. Clinical studies show if it is safe and effective and provide information on any side effects. All clinical studies must be reviewed by a regulatory agency.  

For more information regarding the study, visit the About BrILliance section.

To see if you are eligible, take our questionnaire in the Am I eligible? section.

Approximately 150 people worldwide are expected to participate. To find your nearest study site, please visit our Site Finder.

If you join the study, there are certain things you will be expected to do. This includes attending study visits and undergoing certain assessments and procedures.  

Your length of participation will vary depending on your response to the study drug. 

You may benefit by receiving additional health check-ups on top of your regular medical care. You will also help us increase our medical understanding of advanced solid tumors, which may benefit others in the future.  

The Informed Consent Form talks about all known risks. Before starting a clinical study, you must sign the document. Signing it means you agree to participate in the research study. The study staff will walk you through the study schedule and design. Ask questions so you are comfortable moving forward.

Clinical studies are 100% voluntary. You can stop at any time.  

The study is taking place in multiple countries worldwide. To find a study site near you, visit our Site Finder.